A roadmap to evaluate the proteome-wide selectivity of covalent kinase inhibitors

Kinases are principal components of signal transduction pathways and the focus of intense basic and drug discovery research. Irreversible inhibitors that covalently modify non-catalytic cysteines in kinase active-sites have emerged as valuable probes and approved drugs. Many protein classes, however...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lanning, Bryan R., Whitby, Landon R., Dix, Melissa M., Douhan, John, Gilbert, Adam M., Hett, Erik C., Johnson, Theodore O., Joslyn, Chris, Kath, John C., Niessen, Sherry, Roberts, Lee R., Schnute, Mark E., Wang, Chu, Hulce, Jonathan J., Wei, Baoxian, Whiteley, Laurence O., Hayward, Matthew M., Cravatt, Benjamin F.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4138289/
https://ncbi.nlm.nih.gov/pubmed/25038787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchembio.1582
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares